- Record: found
- Abstract: not found
- Article: not found
A phase 1, open-label, dose escalation study of enoblituzumab (MGA271) in pediatric patients with B7-H3-expressing relapsed or refractory solid tumors
Kenneth DeSantes, John Maris, Kimberly McDowell, Crystal Mackall, Sadhna Shankar, Jim Vasselli, Francine Chen, Deryk Loo, Paul Moore, Jon M. Wigginton, Paul Sondel, K DeSantes, JM Maris, K MCDOWELL, Kimberly McDowell, J.M. Maris, C. Mackall, S Shankar, J Vasselli, F Chen, D. Loo, P.A. Moore, J.M. Wigginton, MM John, PA Moore, JM Wigginton, MS Paul
2017
Read this article at
ScienceOpenPublisher
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.